Related Experiment Video
Updated: Oct 13, 2025

Using the E1A Minigene Tool to Study mRNA Splicing Changes
Published on: April 22, 2021
CCNE1 and E2F1 Partially Suppress G1 Phase Arrest Caused by Spliceostatin A Treatment
1School of Medicine, University of Toyama, Toyama 930-0194, Japan.
Abstract:
The potent splicing inhibitor spliceostatin A (SSA) inhibits cell cycle progression at the G1 and G2/M phases. We previously reported that upregulation of the p27 cyclin-dependent kinase inhibitor encoded by CDKN1B and its C-terminal truncated form, namely p27*, which is translated from CDKN1B pre-mRNA, is one of the causes of G1 phase arrest caused by SSA treatment. However, the detailed molecular mechanism underlying G1 phase arrest caused by SSA treatment remains to be elucidated. In this study, we found that SSA treatment caused the downregulation of cell cycle regulators, including CCNE1, CCNE2, and E2F1, at both the mRNA and protein levels. We also found that transcription elongation of the genes was deficient in SSA-treated cells. The overexpression of CCNE1 and E2F1 in combination with CDKN1B knockout partially suppressed G1 phase arrest caused by SSA treatment. These results suggest that the downregulation of CCNE1 and E2F1 contribute to the G1 phase arrest induced by SSA treatment, although they do not exclude the involvement of other factors in SSA-induced G1 phase arrest.
Insights
Spliceostatin A (SSA) causes G1 phase arrest by downregulating cell cycle genes CCNE1 and E2F1. This contributes to SSA
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Cancer Research
Background:
- Spliceostatin A (SSA) is a potent splicing inhibitor affecting cell cycle progression.
- Previous studies linked SSA to G1 phase arrest via p27 and p27* upregulation.
- The precise molecular mechanisms of SSA-induced G1 arrest require further investigation.
Purpose of the Study:
- To elucidate the detailed molecular mechanisms of G1 phase arrest induced by SSA.
- To investigate the role of cell cycle regulators CCNE1, CCNE2, and E2F1 in SSA's effects.
Main Methods:
- Analysis of mRNA and protein levels of cell cycle regulators in SSA-treated cells.
- Assessment of transcription elongation efficiency for key genes.
- Experimental manipulation (overexpression and knockout) to evaluate gene function in G1 arrest.
Main Results:
- SSA treatment led to the downregulation of CCNE1, CCNE2, and E2F1 at both mRNA and protein levels.
- Transcription elongation was impaired for these cell cycle-related genes in SSA-treated cells.
- Overexpression of CCNE1 and E2F1, along with CDKN1B knockout, partially rescued SSA-induced G1 phase arrest.
Conclusions:
- Downregulation of CCNE1 and E2F1 contributes significantly to SSA-induced G1 phase arrest.
- Impaired transcription elongation of CCNE1 and E2F1 is a key mechanism.
- Other factors may also be involved in the complex G1 arrest induced by SSA.
More Related Videos
11:49Author Spotlight: Establishing CENP-E Knockout HeLa Cells – A Novel Approach to Study Kinesin-7 CENP-E Biology and its Inhibitors
Published on: June 23, 2023
09:41Functional Assessment of Kinesin-7 CENP-E in Spermatocytes Using In Vivo Inhibition, Immunofluorescence and Flow Cytometry
Published on: December 28, 2021
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...